BioCentury
ARTICLE | Company News

Agen Biomedical Ltd., Immunomedics deal

October 29, 2001 8:00 AM UTC

IMMU non-exclusively licensed its method of directly labeling antibodies with technetium-99m (Tc-99m) to Agen for worldwide use with Agen’s clot imaging agent under development. The clot imaging agent...